Last week the Federal Circuit Court handed down what seemed to many a funny decision: that human genes are patentable. Myriad Genetics owns patents for two tumor suppressor genes, BRCA1 and BRCA2 (mutations of these genes are correlated with increased incidence of breast cancer, making them of great interest to doctors and scientists). Myriad was sued by doctors and researchers who claim that genes fall into the category of “products of nature,” which makes them unpatentable, but the court disagreed.
Posts tagged with: patent
As I’ve said before, some of the most interesting debates are those that break down along atypical lines: for example, by splitting dedicated limited government advocates rather than pitting them against statists. Back in 2001, the Journal of Markets & Morality conducted a controversy between two libertarian-leaning economists, Julio Cole and Paul Cleveland, concerning copyright and patent law.
In the Last Week
- The New Legalism: Missional, Radical, Narcissistic, and Shamed (841 views)
by Anthony Bradley - What capitalists can learn from Pope Francis (443 views)
by Elise Hilton - Paying For College By Selling Yourself (328 views)
by Elise Hilton - The Failing Success of Population Control in the Developing World (269 views)
by Anthony Bradley - 7 Great Books for Memorial Day (262 views)
by Ray Nothstine
- Acton Commentary (257)
- Acton Media (76)
- Acton University (46)
- Bible and Theology (575)
- Christian Social Thought (245)
- Economic Freedom (71)
- Economics (104)
- General (585)
- Individual Liberty (164)
- Interviews (27)
- News and Events (2315)
- On Call in Culture (52)
- Poverty (115)
- PowerBlog Ramblings (53)
- PowerLinks (117)
- Programs (64)
- Public Policy (2059)
- Publications (212)
- Religious Liberty (34)
- Shareholder Activism (3)
- Shareholder Proxy Resolutions (3)
- Technology (15)
- Vatican (225)
- Virtue (48)
- Vocation (3)